Capsicum Composition Ratio for Cardiometabolic Syndrome Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current capsicum compositions do not effectively characterize specific combinations of capsaicinoids and non-capsaicinoids, such as flavonoids and saponins, in a ratio that exhibits beneficial biological effects, particularly in managing cardiometabolic syndrome and associated cardiovascular risks.
Innovation Solution
Development of capsicum compositions comprising capsaicinoids and non-capsaicinoids in a specific ratio of 1:0.1 to 1:10, including major capsaicinoids like capsaicin and dihydrocapsaicin, and polyphenols like flavonoids, which are identified and quantified using advanced analytical techniques, and prepared using food-grade solvents for safe human consumption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If capsicum compositions use conventional extraction methods without specific ratio control, then extraction process is simple, but biological efficacy is insufficient
Solution Approach 1:
The patent applies parameter changes by precisely controlling the ratio of capsaicinoids to non-capsaicinoids (specifically saponins and polyphenols) in the capsicum composition. By optimizing this chemical composition parameter to specific ranges, the invention achieves enhanced biological efficacy for managing cardiometabolic syndrome while maintaining a feasible extraction process using food-grade solvents.
Solution Approach 2:
The invention employs composite materials by creating a capsicum composition that intentionally combines multiple bioactive compounds (capsaicinoids, saponins, and polyphenols) in specific ratios. This composite approach leverages the synergistic effects of different compound classes to achieve superior therapeutic outcomes compared to single-compound preparations.
2Reliability
If capsicum compositions focus only on capsaicinoids, then composition is simple, but therapeutic effect is limited
Solution Approach 1:
The patent applies composite materials by creating a capsicum composition that intentionally combines multiple bioactive compounds (capsaicinoids, saponins, and polyphenols) in specific ratios. This composite approach leverages the synergistic effects of different compound classes to achieve superior therapeutic outcomes compared to single-compound preparations.
Solution Approach 2:
The invention applies parameter changes by precisely controlling the ratio of capsaicinoids to non-capsaicinoids (specifically saponins and polyphenols) in the capsicum composition. By optimizing this chemical composition parameter to specific ranges, the invention achieves enhanced biological efficacy for managing cardiometabolic syndrome while maintaining a feasible extraction process using food-grade solvents.
3Manufacturing precision
If advanced analytical techniques are used for composition characterization, then composition precision is improved, but manufacturing complexity increases
Solution Approach 1:
The patent applies parameter changes by precisely controlling the ratio of capsaicinoids to non-capsaicinoids (specifically saponins and polyphenols) in the capsicum composition. By optimizing this chemical composition parameter to specific ranges, the invention achieves enhanced biological efficacy for managing cardiometabolic syndrome while maintaining a feasible extraction process using food-grade solvents.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The capsicum compositions effectively manage cardiometabolic syndrome by reducing oxidative stress, inflammatory markers, inhibiting pancreatic lipase, and enhancing lipolysis, thereby improving cardiovascular health and associated risk factors like body weight, lipid profiles, and blood glucose levels.
Implementation Method 1
Capsicum compositions described herein can reduce cardiometabolic stress in a subject, in need thereof, by inhibiting pancreatic lipase enzyme and enhancing lipolysis
Implementation Method 2
The composition also improves cardiovascular endothelial function by reducing oxidative stress and inflammatory markers
Data Source
AI summary
Capsicum compositions are described that include biologically active constituents non-capsaicinoids and capsaicinoids in a specific ratio are useful for the treatment and management of cardiometabolic syndrome and associated risk factors, in a subject in need thereof. The capsicum compositions include a capsicum extract which is prepared by extracting capsicum pods by using suitable polar and non-polar solvents. Capsicum compositions include non-capsaicinoid components like saponins and polyphenols such as flavonoids, which along with capsaicinoids effectively reduce risk factors of cardiometabolic syndrome and also reduce oxidative stress on vital body organs by reducing inflammatory and/or oxidative markers. The capsicum compositions inhibit pancreatic lipase enzyme and enhance lipolysis, when administered in an effective amount to a subject in need thereof. Capsicum compositions as described herein are prepared by human intervention and are safe for consumption.


